In focus · trending topic

Phase 1b interim update

2 stories · following the connections

Voyager Therapeutics Announces Additional Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease

By Nasdaq OMXApr 25, 2017, 11:02 AM UTC

Voyager Therapeutics Announces Positive Interim Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease

By Nasdaq OMXDec 7, 2016, 9:05 PM UTC